After H-Y stage classification, MMP3 levels were found to be significantly lower in early-stage PD patients than in healthy controls, while MMP9 levels were found to be significantly higher in early-stage and advanced-stage PD patients than in healthy controls. Here, MMP3 is linked to Parkinson disease.